• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

The Vault Project

  • Start Here
  • About
  • Articles
  • Vaccines
    • Vaccine Exemptions
      • Religious Exemptions
      • FAQ: Vaccine Exemptions
    • Vaccine Mandates
    • U.S. Vaccines
      • Pfizer/BioNTech
      • Moderna
      • Johnson & Johnson
  • Nuremberg Code
    • Informed Consent
  • The Archive
    • Natural Immunity
    • Pfizer Research, Studies and Censored Science
    • Vaccine Injuries
    • COVID Treatments
      • Ivermectin
      • Hydroxychloroquine
    • Face Masks
    • Videos
  • Lawsuits
  • Resources
    • Employer Vaccine Mandates
    • Religious Exemptions
    • Templates
  • Contact Us

Novavax

FDA, CDC Authorize ‘Mix and Match’ Novavax COVID Booster for Adults, Bypass Advisory Panels

October 20, 2022 by The Vault Project Leave a Comment

The U.S. Food and Drug Administration (FDA) and Centers for Disease Control and Prevention (CDC) on Wednesday authorized a first booster dose of Novavax’s COVID-19 vaccine for adults, including those who received Pfizer, Moderna or Johnson & Johnson as their primary series. The FDA, in a factsheet for healthcare providers, said adults ages 18 and older […]

Tweet
Share
Share
Pin

Filed Under: COVID Vaccines, Novavax, Public Health Tagged With: CDC, FDA, Novavax, Public health, Vaccines

EU Says Novavax COVID Vaccine Must Carry Heart Inflammation Warning

August 3, 2022 by The Vault Project Leave a Comment

The European Medicines Agency (EMA) is requesting more data from U.S. vaccine maker Novavax and said its COVID-19 vaccine — marketed under the brand names “Nuvaxovid and Covovax” — carry a warning of two types of heart inflammation after a small number of cases were reported in those who received the vaccine.  According to a […]

Tweet
Share
Share
Pin

Filed Under: COVID Vaccines, Novavax, Vaccines Tagged With: COVID vaccines, Heart inflammation, Myocarditis, Novavax, Vaccines

FDA Experts Recommend Emergency Authorization of Novavax COVID Vaccine, Ignore Risk of Heart Inflammation

June 10, 2022 by The Vault Project Leave a Comment

The U.S. Food and Drug Administration’s (FDA) vaccine advisors recommended the Novavax COVID-19 vaccine for emergency use authorization on Tuesday, paving the way for a fourth U.S. vaccine. The panel’s vote was 21 in favor of authorizing Novavax and one abstention. However, FDA authorization could be delayed because the company informed the agency just four […]

Tweet
Share
Share
Pin

Filed Under: COVID Vaccines, Novavax, Vaccines Tagged With: COVID policies, COVID vaccines, FDA, Novavax

Primary Sidebar

Email Newsletter

Sign up to receive updates from The Vault Project.

Trending Articles

What You Need to Know About Your Right to a COVID Vaccine Religious Exemption in the Workplace

Aborted Fetal Ingredients in COVID Vaccines

What You Need to Know About Aborted Fetal Ingredients and COVID Vaccines

A Physician’s Brilliant Request for a Religious Exemption

A Sample Letter for the Healthcare Employer Who Grants a Vaccine Religious Exemption, but Does Not Provide an Accommodation

A Sample Religious Exemption Letter for Your Pastor

A Sample Letter Your Pastor Can Sign for Your Vaccine Religious Exemption Request

A Template for Your Employer’s “Request for a Religious Exemption to the COVID-19 Vaccination” Form

The Government’s “Religious Exemption” Process for COVID Vaccines Is a Farce

A Template for the “COVID-19 Vaccine Exemption Interactive Dialogue Questions for Employee” Form

Footer

Disclaimer and Disclosures

The Vault Project is a website for informational and educational purposes only. To learn more, please visit our disclaimer and disclosures page.

Privacy Policy

Our team is dedicated to protecting your privacy. Should you have any questions about how we use your data, please read our  privacy policy.

Contact Us

Do you have a question or comment for The Vault Project? You can email us at info@thevaultproject.org or visit our contact page.